Marksans Pharma’s arm gets Marketing Authorisation for Levetiracetam Relonchem Oral Solution

28 May 2024 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization for the product Levetiracetam Relonchem 100 mg/mL Oral Solution from UK Medicines and Healthcare products Regulatory Agency (MHRA). The product will be manufactured at the Group’s UK manufacturing facility. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×